Literature DB >> 2330937

"Hello, may we help you?" A study of attrition prevention at the time of the first phone contact with substance-abusing clients.

M J Stark1, B K Campbell, C V Brinkerhoff.   

Abstract

The problem of early attrition from treatment is pervasive throughout community mental health and is particularly high for substance-abusing clients. In spite of the severity of this problem and the potential for successful interventions, there have not been many studies that attempt to reduce the dropout rate of drug abusers. The purpose of this research was to test the effectiveness of attrition prevention procedures at the time of the client's first phone contact with the clinic. Callers were either given an appointment or told to come to the clinic the same day. A second variable was the presence or absence of an experimenter-initiated dialogue designed to help subjects predict possible obstacles to attendance and to generate potential solutions to those barriers. Subjects in the same day conditions showed at a higher rate than those given appointments, but the addition of the dialogue had no effect on client behavior. The results are discussed in terms of how mental health professionals can find cost effective interventions that prevent drug abuse treatment dropout.

Mesh:

Substances:

Year:  1990        PMID: 2330937     DOI: 10.3109/00952999009001573

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  22 in total

1.  Individual and system influences on waiting time for substance abuse treatment.

Authors:  Carey J A Carr; Jiangmin Xu; Cristina Redko; D Timothy Lane; Richard C Rapp; John Goris; Robert G Carlson
Journal:  J Subst Abuse Treat       Date:  2007-05-23

2.  Waiting Time as a Barrier to Treatment Entry: Perceptions of Substance Users.

Authors:  Cristina Redko; Richard C Rapp; Robert G Carlson
Journal:  J Drug Issues       Date:  2006-09

3.  The accelerated intake: a method for increasing initial attendance to outpatient cocaine treatment.

Authors:  D S Festinger; R J Lamb; K C Kirby; D B Marlowe
Journal:  J Appl Behav Anal       Date:  1996

4.  Examining access to addiction treatment: scheduling processes and barriers.

Authors:  Andrew Quanbeck; Anna Wheelock; James H Ford; Alice Pulvermacher; Victor Capoccia; David Gustafson
Journal:  J Subst Abuse Treat       Date:  2012-09-27

Review 5.  Mindfulness-based treatment to prevent addictive behavior relapse: theoretical models and hypothesized mechanisms of change.

Authors:  Katie Witkiewitz; Sarah Bowen; Erin N Harrop; Haley Douglas; Matthew Enkema; Carly Sedgwick
Journal:  Subst Use Misuse       Date:  2014-04       Impact factor: 2.164

6.  A business case for quality improvement in addiction treatment: evidence from the NIATx collaborative.

Authors:  Andrew R Quanbeck; Lynn Madden; Eldon Edmundson; James H Ford; K John McConnell; Dennis McCarty; David H Gustafson
Journal:  J Behav Health Serv Res       Date:  2012-01       Impact factor: 1.505

7.  Failure to get into substance abuse treatment.

Authors:  Dennis G Fisher; Grace L Reynolds; Laura H D'Anna; David W Hosmer; Kholoud Hardan-Khalil
Journal:  J Subst Abuse Treat       Date:  2016-11-16

8.  Improving substance abuse data systems to measure 'waiting time to treatment': lessons learned from a quality improvement initiative.

Authors:  Kim A Hoffman; Andrew Quanbeck; James H Ford; Fritz Wrede; Dagan Wright; Dawn Lambert-Wacey; Phil Chvojka; Andrew Hanchett; Dennis McCarty
Journal:  Health Informatics J       Date:  2011-12       Impact factor: 2.681

9.  Methadone maintenance in general practice: patients, workload, and outcomes.

Authors:  P Wilson; R Watson; G E Ralston
Journal:  BMJ       Date:  1994-09-10

10.  Client incentives versus contracting and staff incentives: how care continuity interventions in substance abuse treatment can improve residential to outpatient transition.

Authors:  Shauna P Acquavita; Sandra Stershic; Rajni Sharma; Maxine Stitzer
Journal:  J Subst Abuse Treat       Date:  2013-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.